$2.4T
Total marketcap
$82.89B
Total volume
BTC 51.25%     ETH 14.73%
Dominance

NeoImmuneTech, Inc. 950220.KQ Stock

1446 KRW {{ price }} -3.920266% {{change_pct}}%
Exchange
KOSDAQ
Market Cap
28.59B KRW
LOW - HIGH [24H]
1443 - 1499 KRW
VOLUME [24H]
202.87K KRW
{{ volume }}
P/E Ratio
0
Earnings per share
0 KRW

NeoImmuneTech, Inc. Price Chart

NeoImmuneTech, Inc. 950220.KQ Financial and Trading Overview

NeoImmuneTech, Inc. stock price 1446 KRW
Previous Close 2640 KRW
Open 2620 KRW
Bid 2385 KRW x N/A
Ask 2395 KRW x N/A
Day's Range 2370 - 2715 KRW
52 Week Range 2370 - 5690 KRW
Volume 2.81M KRW
Avg. Volume 497.43K KRW
Market Cap N/A
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) 0 KRW
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

950220.KQ Valuation Measures

Enterprise Value 234.87B KRW
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -3.729

Trading Information

NeoImmuneTech, Inc. Stock Price History

Beta (5Y Monthly) N/A
52-Week Change -36.53%
S&P500 52-Week Change 20.43%
52 Week High 5690 KRW
52 Week Low 2370 KRW
50-Day Moving Average 3168.9 KRW
200-Day Moving Average 3712.18 KRW

950220.KQ Share Statistics

Avg. Volume (3 month) 497.43K KRW
Avg. Daily Volume (10-Days) 392.01K KRW
Shares Outstanding N/A
Float 58.27M
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 2.22%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate N/A
Trailing Annual Dividend Yield N/A
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2021
Most Recent Quarter (mrq) September 30, 2022
Next Fiscal Year End December 31, 2022

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -22.32%
Return on Equity (ttm) -47.13%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -62988464128 KRW
Net Income Avi to Common (ttm) -72829288448 KRW
Diluted EPS (ttm) N/A
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 140.62B KRW
Total Cash Per Share (mrq) 1422.85 KRW
Total Debt (mrq) 5.38B KRW
Total Debt/Equity (mrq) 4 KRW
Current Ratio (mrq) 4.347
Book Value Per Share (mrq) N/A

Cash Flow Statement

Operating Cash Flow (ttm) -44233465856 KRW
Levered Free Cash Flow (ttm) -20615557120 KRW

Profile of NeoImmuneTech, Inc.

Country South Korea
State MD
City Rockville
Address 2400 Research Boulevard
ZIP 20850
Phone 240 801 9065
Website https://www.neoimmunetech.com
Industry
Sector(s)
Full Time Employees 85

NeoImmuneTech, Inc., a clinical-stage T cell-focused biotech company, engages in the research, development, production, and sales of immuno-oncology drugs in the United States. It is developing NT-I7, a clinical-stage long-acting human IL-7 for oncologic and immunologic indications, as well as infectious diseases. The company was founded in 2014 and is headquartered in Rockville, Maryland.

Q&A For NeoImmuneTech, Inc. Stock

What is a current 950220.KQ stock price?

NeoImmuneTech, Inc. 950220.KQ stock price today per share is 1446 KRW.

How to purchase NeoImmuneTech, Inc. stock?

You can buy 950220.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for NeoImmuneTech, Inc.?

The stock symbol or ticker of NeoImmuneTech, Inc. is 950220.KQ.

How many shares does NeoImmuneTech, Inc. have in circulation?

The max supply of NeoImmuneTech, Inc. shares is 19.77M.

What is NeoImmuneTech, Inc. Price to Earnings Ratio (PE Ratio)?

NeoImmuneTech, Inc. PE Ratio is now.

What was NeoImmuneTech, Inc. earnings per share over the trailing 12 months (TTM)?

NeoImmuneTech, Inc. EPS is 0 KRW over the trailing 12 months.